TB-500 (Thymosin Beta-4) FAQ: Your Questions Answered
The questions below are the ones that come up specifically about TB-500 (Thymosin Beta-4), rather than general peptide questions that apply to everything.
In plain English
Common questions: whether it is the same as Thymosin Beta-4 (it is a fragment, not the whole protein), why oxygen damage matters so much for this one specifically, and why it is so often studied alongside BPC-157.
What TB-500 (Thymosin Beta-4) actually is
TB-500 is a lab-made fragment of Thymosin Beta-4, a protein present in almost every cell in the body and especially concentrated in the fluid around a wound. Research on it centres on cell movement — the internal scaffolding that lets a cell change shape and travel where it is needed.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
TB-500 (Thymosin Beta-4) — common questions
Is TB-500 the same molecule as Thymosin Beta-4?
No — TB-500 is a synthetic fragment corresponding to the actin-binding region of the full 43-residue protein, not the complete protein. The literature frequently uses the names interchangeably, which is worth accounting for when comparing published studies.
Why does methionine oxidation matter for TB-500 specifically?
Methionine sits within the region responsible for actin interaction, so oxidation is not a cosmetic purity issue — it is a modification at the functionally studied site. It is also easy to detect: a +16 Da species on LC-MS, or an early-eluting shoulder on the HPLC trace.
Does TB-500 require a special solvent?
No. It is strongly hydrophilic and dissolves readily in bacteriostatic water. Its handling difficulty is oxidative rather than solubility-related, which is the opposite of a compound like IGF-1 LR3.
How should TB-500 solution look?
Clear and colourless. Any visible particulate or opalescence after full dissolution warrants discarding the vial rather than filtering it.
Why is TB-500 studied alongside BPC-157?
They are mechanistically complementary rather than redundant: research on BPC-157 centres on vascular and growth-factor signalling, while TB-500 research centres on actin-mediated cell migration. Study designs often examine them in parallel for exactly that reason.
What TB-500 (Thymosin Beta-4) is studied for
The defining studied mechanism: binding G-actin and influencing the polymerisation equilibrium that governs cell motility.
Investigated in models where directed cell movement into a tissue defect is the measured endpoint.
Two of the better-populated preclinical literatures for the parent protein.
Studied for effects on inflammatory signalling in tissue-injury models.
Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.
More TB-500 (Thymosin Beta-4) reference
Lyophilized and reconstituted storage conditions, plus the practical working window.
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
FAQ reference for other compounds
TB-500 (Thymosin Beta-4) is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.